3.815
Precedente Chiudi:
$3.69
Aprire:
$3.69
Volume 24 ore:
2.91M
Relative Volume:
0.61
Capitalizzazione di mercato:
$1.35B
Reddito:
$6.23M
Utile/perdita netta:
$-95.90M
Rapporto P/E:
-9.7821
EPS:
-0.39
Flusso di cassa netto:
$-68.47M
1 W Prestazione:
+3.66%
1M Prestazione:
-21.13%
6M Prestazione:
+151.64%
1 anno Prestazione:
+466.41%
Precigen Inc Stock (PGEN) Company Profile
Nome
Precigen Inc
Settore
Industria
Telefono
301-556-9900
Indirizzo
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Confronta PGEN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
PGEN
Precigen Inc
|
3.825 | 1.31B | 6.23M | -95.90M | -68.47M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
453.50 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.39 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
846.16 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
394.74 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.59 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-15 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-03-22 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Iniziato | JP Morgan | Neutral |
| 2022-11-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-02-25 | Iniziato | Stifel | Buy |
| 2021-02-22 | Iniziato | Wells Fargo | Overweight |
| 2021-02-18 | Iniziato | B. Riley Securities | Buy |
| 2020-05-08 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Precigen Inc Borsa (PGEN) Ultime notizie
Precigen, Inc. (NASDAQ:PGEN) is definitely on the radar of institutional investors who own 31% of the company - Yahoo Finance
Precigen (NASDAQ:PGEN) Trading 5.3% HigherHere's What Happened - MarketBeat
Diametric Capital LP Buys New Holdings in Precigen, Inc. $PGEN - MarketBeat
Precigen Stock Up 280% in a Year — Is FDA Approval Behind This Big New Investor Bet? - sharewise.com
Patient Capital Management LLC Sells 1,103,560 Shares of Precigen, Inc. $PGEN - MarketBeat
Precigen (PGEN): Valuation in Focus After FDA Approval and Strengthened Cash Position - Sahm
Free cash flow per share of Precigen Inc – BX:I5X - TradingView
Can Precigen's (PGEN) Revenue Surge Offset Concerns About Its Expanding Losses? - simplywall.st
Precigen Is Still A Buy After The Papzimeos Rally (NASDAQ:PGEN) - Seeking Alpha
Precigen Insider Sold Shares Worth $12,291,748, According to a Recent SEC Filing - marketscreener.com
Precigen, Inc. Opens with a 5.13% Gain Amid Ongoing Challenges - Markets Mojo
Precigen, Inc. Soars 26.94% to Hit Intraday High of $5.00 - Markets Mojo
Precigen, Inc. Hits Day High with 25.65% Surge in Stock Price - Markets Mojo
Is Precigen (NASDAQ:PGEN) Weighed On By Its Debt Load? - 富途牛牛
Precigen (PGEN) director Kirk sells shares worth $12.3 million By Investing.com - Investing.com Australia
Precigen (PGEN) director Kirk sells shares worth $12.3 million - Investing.com
[Form 4] PRECIGEN, INC. Insider Trading Activity - Stock Titan
Precigen, Inc. Hits Day Low of $3.88 Amid Price Pressure - Markets Mojo
Precigen, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
Precigen Stock Opens Weak with 11.75% Gap Down Amid Market Concerns - Markets Mojo
Shareholder Kapital Joe LLC Files To Sell 942,832 Of Precigen Inc [PGEN] - TradingView
Is Precigen Inc. stock supported by strong cash flowsJuly 2025 Momentum & Reliable Intraday Trade Plans - newser.com
Can technical indicators confirm Precigen Inc.’s reversal2025 Risk Factors & Safe Capital Growth Trade Ideas - newser.com
How to integrate Precigen Inc. into portfolio analysis tools - newser.com
Earnings visualization tools for Precigen Inc.2025 Institutional Moves & Short-Term Trading Alerts - newser.com
Published on: 2025-11-19 18:31:23 - newser.com
How Precigen Inc. stock performs in interest rate cyclesJuly 2025 Market Mood & Safe Swing Trade Setups - newser.com
Will Precigen Inc. stock benefit from commodity prices2025 Investor Takeaways & Weekly Consistent Profit Watchlists - newser.com
Shareholder Kapital Joe LLC Files To Sell 1,086,153 Of Precigen Inc [PGEN] - TradingView
Precigen (PGEN) Q3 2025 Earnings Call Transcript - AOL.com
Is Precigen Inc. stock in correction or buying zone2025 Earnings Surprises & Risk Adjusted Buy/Sell Alerts - newser.com
Using data tools to time your Precigen Inc. exit2025 Valuation Update & AI Based Buy and Sell Signals - newser.com
Tools to assess Precigen Inc.’s risk profileQuarterly Market Summary & Daily Price Action Insights - newser.com
Will Precigen Inc. stock benefit from AI adoptionJuly 2025 Fed Impact & Daily Market Momentum Tracking - newser.com
Using R and stats models for Precigen Inc. forecastingRisk Management & Weekly Top Performers Watchlists - newser.com
US High Growth Tech Stocks to Watch in November 2025 - simplywall.st
Vaxart, Precigen among biotech gainers after Q3 results - MSN
Is Now The Right Time To Watch Precigen's Commercial Launch Story? - RTTNews
Intraday pattern recognizer results for Precigen Inc.Quarterly Portfolio Report & Free Community Supported Trade Ideas - newser.com
Precigen Inc Azioni (PGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Precigen Inc Azioni (PGEN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| KIRK RANDAL J | Director |
Nov 19 '25 |
Sale |
4.47 |
1,086,153 |
4,855,104 |
7,434,384 |
| KIRK RANDAL J | Director |
Nov 20 '25 |
Sale |
4.08 |
942,832 |
3,846,755 |
6,491,552 |
| KIRK RANDAL J | Director |
Nov 21 '25 |
Sale |
3.83 |
937,308 |
3,589,890 |
5,554,244 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):